Literature DB >> 31537637

HIV and pericardial fat are associated with abnormal cardiac structure and function among Ugandans.

Jonathan Buggey1, Leo Yun2, Chung-Lieh Hung3, Cissy Kityo4, Grace Mirembe4, Geoffrey Erem5,6, Tiffany Truong7, Isaac Ssinabulya6,8, W H Wilson Tang9, Brian D Hoit1,7, Grace A McComsey7,10,11, Chris T Longenecker12,7.   

Abstract

OBJECTIVES: To examine the relationship between pericardial fat (PCF) and cardiac structure and function among HIV-infected patients in the sub-Saharan African country of Uganda. People living with HIV (PLHIV) have altered fat distribution and an elevated risk for heart failure. Whether altered quantity and radiodensity of fat surrounding the heart relates to cardiac dysfunction in this population is unknown.
METHODS: One hundred HIV-positive Ugandans on antiretroviral therapy were compared with 100 age and sex-matched HIV-negative Ugandans; all were >45 years old with >1 cardiovascular disease risk factor. Subjects underwent ECG-gated non-contrast cardiac CT and transthoracic echocardiography with speckle tracking strain imaging. Multivariable linear and logistic regression models were used to explore the association of PCF with echocardiographic outcomes.
RESULTS: Median age was 55% and 62% were female. Compared with uninfected controls, PLHIV had lower body mass index (27 vs 30, p=0.02) and less diabetes (26% vs 45%, p=0.005). Median left ventricular (LV) ejection fraction was 67%. In models adjusted for traditional risk factors, HIV was associated with 10.3 g/m2 higher LV mass index (LVMI) (95% CI 3.22 to 17.4; p=0.005), 0.87% worse LV global longitudinal strain (GLS) (95% CI -1.66 to -0.07; p=0.03) and higher odds of diastolic dysfunction (OR 1.96; 95% CI 0.95 to 4.06; p=0.07). In adjusted models, PCF volume was significantly associated with increased LVMI and worse LV GLS, while PCF radiodensity was associated with worse LV GLS (all p<0.05).
CONCLUSIONS: In Uganda, HIV infection, PCF volume and density are associated with abnormal cardiac structure and function. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  HIV; LV GLS; pericardial fat

Mesh:

Year:  2019        PMID: 31537637      PMCID: PMC7927634          DOI: 10.1136/heartjnl-2019-315346

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

Review 1.  Global epidemiology of HIV.

Authors:  Jade Fettig; Mahesh Swaminathan; Christopher S Murrill; Jonathan E Kaplan
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

2.  Adiposopathy is "sick fat" a cardiovascular disease?

Authors:  Harold E Bays
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

3.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Sherif F Nagueh; Otto A Smiseth; Christopher P Appleton; Benjamin F Byrd; Hisham Dokainish; Thor Edvardsen; Frank A Flachskampf; Thierry C Gillebert; Allan L Klein; Patrizio Lancellotti; Paolo Marino; Jae K Oh; Bogdan Alexandru Popescu; Alan D Waggoner
Journal:  J Am Soc Echocardiogr       Date:  2016-04       Impact factor: 5.251

4.  Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters.

Authors:  Janet Lo; Suhny Abbara; Jose A Rocha-Filho; Leon Shturman; Jeffrey Wei; Steven K Grinspoon
Journal:  AIDS       Date:  2010-08-24       Impact factor: 4.177

Review 5.  Heart fat in HIV: marker or mediator of risk?

Authors:  Jonathan Buggey; Chris T Longenecker
Journal:  Curr Opin HIV AIDS       Date:  2017-11       Impact factor: 4.283

6.  Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis.

Authors:  Michael Brener; Kerunne Ketlogetswe; Matthew Budoff; Lisa P Jacobson; Xiuhong Li; Panteha Rezaeian; Aryabod Razipour; Frank J Palella; Lawrence Kingsley; Mallory D Witt; Richard T George; Wendy S Post
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

Review 7.  Cardiac dysfunction in pauci symptomatic human immunodeficiency virus patients: a meta-analysis in the highly active antiretroviral therapy era.

Authors:  Enrico Cerrato; Fabrizio D'Ascenzo; Giuseppe Biondi-Zoccai; Andrea Calcagno; Simone Frea; Walter Grosso Marra; Davide Castagno; Pierluigi Omedè; Giorgio Quadri; Filippo Sciuto; Davide Presutti; Giacomo Frati; Stefano Bonora; Claudio Moretti; Fiorenzo Gaita
Journal:  Eur Heart J       Date:  2013-01-18       Impact factor: 29.983

8.  Determinants of Left Ventricular Hypertrophy and Diastolic Dysfunction in an HIV Clinical Cohort.

Authors:  Nwora Lance Okeke; Fawaz Alenezi; Gerald S Bloomfield; Allison Dunning; Meredith E Clement; Svati H Shah; Susanna Naggie; Eric J Velazquez
Journal:  J Card Fail       Date:  2018-06-30       Impact factor: 5.712

9.  Increased pericardial fat accumulation is associated with increased intramyocardial lipid content and duration of highly active antiretroviral therapy exposure in patients infected with human immunodeficiency virus: a 3T cardiovascular magnetic resonance feasibility study.

Authors:  Mariana Diaz-Zamudio; Damini Dey; Troy LaBounty; Michael Nelson; Zhaoyang Fan; Lidia S Szczepaniak; Bill Pei-Chin Hsieh; Ronak Rajani; Daniel Berman; Debiao Li; Rohan Dharmakumar; W David Hardy; Antonio Hernandez Conte
Journal:  J Cardiovasc Magn Reson       Date:  2015-10-31       Impact factor: 5.364

10.  Silent ischemic heart disease and pericardial fat volume in HIV-infected patients: a case-control myocardial perfusion scintigraphy study.

Authors:  Ulrik S Kristoffersen; Anne-Mette Lebech; Niels Wiinberg; Claus L Petersen; Philip Hasbak; Henrik Gutte; Gorm B Jensen; Anne Mette F Hag; Rasmus S Ripa; Andreas Kjaer
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more
  11 in total

Review 1.  Epidemiology, pathophysiology, and prevention of heart failure in people with HIV.

Authors:  Arjun Sinha; Matthew Feinstein
Journal:  Prog Cardiovasc Dis       Date:  2020-01-24       Impact factor: 8.194

Review 2.  Ectopic Fat and Cardiac Health in People with HIV: Serious as a Heart Attack.

Authors:  Ana N Hyatt; Jordan E Lake
Journal:  Curr HIV/AIDS Rep       Date:  2022-08-13       Impact factor: 5.495

3.  High rate of left ventricular hypertrophy on screening echocardiography among adults living with HIV in Malawi.

Authors:  Risa M Hoffman; Florence Chibwana; Ben Allan Banda; Daniel Kahn; Khumbo Gama; Zachary P Boas; Mayamiko Chimombo; Chiulemu Kussen; Judith S Currier; Dan Namarika; Joep van Oosterhout; Sam Phiri; Agnes Moses; Jesse W Currier; Hitler Sigauke; Corrina Moucheraud; Tim Canan
Journal:  Open Heart       Date:  2022-05

4.  Association of epicardial fat with noncalcified coronary plaque volume and with low attenuation plaque in people with HIV.

Authors:  Manel Sadouni; Madeleine Durand; Irina Boldeanu; Coraline Danieli; Paule Bodson-Clermont; Samer Mansour; Jean-Guy Baril; Benoit Trottier; Cécile Tremblay; Carl Chartrand-Lefebvre
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.632

5.  A Meta-Analysis of Different Types of Cardiac Adipose Tissue in HIV Patients.

Authors:  Guang Song; Wei Qiao; Lu Sun; Xiaona Yu
Journal:  Biomed Res Int       Date:  2020-12-09       Impact factor: 3.411

6.  Sex modifies the association between HIV and coronary artery disease among older adults in Uganda.

Authors:  Chris T Longenecker; Milana Bogorodskaya; Seunghee Margevicius; Rashidah Nazzinda; Marcio Sommer Bittencourt; Geoffrey Erem; Sophie Nalukwago; Moises A Huaman; Brian B Ghoshhajra; Mark J Siedner; Steven M Juchnowski; David A Zidar; Grace A McComsey; Cissy Kityo
Journal:  J Int AIDS Soc       Date:  2022-01       Impact factor: 5.396

7.  Subclinical Left Ventricular Systolic Dysfunction in HIV Patients: Prevalence and Associations with Carotid Atherosclerosis and Increased Adiposity.

Authors:  Eleni Athanasiadi; Maria Bonou; Dimitrios Basoulis; Chris J Kapelios; Constantina Masoura; Marina Skouloudi; Sophie Mavrogeni; Constantina Aggeli; Mina Psichogiou; John Barbetseas
Journal:  J Clin Med       Date:  2022-03-24       Impact factor: 4.241

8.  Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People With Treated HIV Infection.

Authors:  Scott E Janus; Claire Sullivan; Justin Morrison; Grace A McComsey; Chris T Longenecker
Journal:  J Acquir Immune Defic Syndr       Date:  2020-03-01       Impact factor: 3.771

Review 9.  HIV-1 Tat: Role in Bystander Toxicity.

Authors:  David Ajasin; Eliseo A Eugenin
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

10.  Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western Kenya.

Authors:  Bethel Woldu; Tecla M Temu; Nicholas Kirui; Bridgette Christopher; Samson Ndege; Wendy S Post; Jemima Kamano; Gerald S Bloomfield
Journal:  Open Heart       Date:  2022-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.